Events
May 8-10, 2022
Target to Patient
The Target to Patient meeting takes place at the Wellcome Genome Campus in Hinxton, UK on May 8-10, 2022. The...
Events
March 15-20, 2022
AD/PD 2022
The AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders took place in Barcelona, Spain and...
Events
November 8-11, 2021
Neuroscience 2021
The Neuroscience 2021 takes place on November 8-11 as a virtual meeting. During the conference, we will present several posters...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2021-06-03
Cellectricon receives funding from Takeda’s open innovation platform
March 3, 2021 Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of...
Events
June 17, 2021
Webcast - The importance of non-neuronal cells in chronic pain – a Drug Discovery perspective
Event info: Pain drug discovery has historically been challenging with few new therapeutics reaching the market. In this webcast, Cellectricon...
News
2021-05-27
Dr. Christian Vægter joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Christian Vægter, Associate Professor and research group leader at Aarhus University, to its Scientific Advisory Board....

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
February 23-25, 2021
Neurodegenerative Drug Development Summit
The 9th Annual Neurodegenerative Drug Development Summit takes place as a digital event on February 23-25. The meeting is dedicated...
Events
February 3, 2021
Webcast - New translational biomarkers and functional studies for AD research
Event info: In this three-part webcast, Professor Henrik Zetterberg first provided an overview presentation on recent developments in biomarker-supported drug...
Events
November 19, 2020. 8 am PST / 11 am EST / 5 pm CET
Webinar - Discovery of NaV1.2 Modulators for Treating Autism Spectrum Disorder
Webinar description: Recent discoveries have shown that loss-of-function variants of SCN2A are causal for a number of neurodevelopmental disorders, including autism spectrum...